FFO
NERV icon

Fortitude Family Office’s Minerva Neurosciences NERV Stock Holding History

Fortitude Family Office’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68K Hold
303
– – ﹤0.01% 1548
2026
Q1 		$1.83K Hold
303
– – ﹤0.01% 1316
2025
Q4 		$1.22K Buy
+303
New +$1.13K ﹤0.01% 1380

Other funds holding NERV

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Fortitude Family Office's NERV Position: Q2 2026 in Review

Fortitude Family Office held its Minerva Neurosciences (NERV) position steady in Q2 2026 at 303 shares worth $1.68K. The position accounts for ﹤0.01% of the portfolio, ranked #1548.

Fortitude Family Office first reported a position in NERV in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.83K in Q1 2026. 6 funds tracked by Wall St. Rank hold NERV as of Q2 2026.

  • Fortitude Family Office held 303 shares of Minerva Neurosciences worth $1.68K as of Q2 2026.
  • Fortitude Family Office left its Minerva Neurosciences share count unchanged in Q2 2026.
  • Minerva Neurosciences made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1548 holding.
  • Fortitude Family Office first reported a position in Minerva Neurosciences in Q4 2025 and has held it in 3 quarters since.
  • Fortitude Family Office's Minerva Neurosciences position peaked at $1.83K in Q1 2026.
  • 6 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.